Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
66%
Infection
60%
Resident
41%
Assay
39%
Patient
35%
Omicron Coronavirus Variant
34%
Immunocompromised Patient
32%
Nursing Home
31%
Host
31%
Antibody Response
29%
mRNA Vaccine
26%
Cells
24%
Protein
23%
Infective Endocarditis
21%
Cytokinesis
21%
Fever
21%
Listeria monocytogenes
21%
Abscess
21%
Syndrome
21%
Immunocompetent Cell
21%
Evaluation Study
21%
Enzyme Linked Immunosorbent Assay
21%
Monoclonal Antibody
21%
Immunosuppressive Drug
21%
Drug Therapy
21%
Parotitis
18%
Antibody
17%
Viremia
17%
Humoral Immunity
15%
Therapeutic Procedure
14%
Woman
14%
Diseases
13%
Gene
13%
Person
13%
Viral Clearance
13%
Monocyte
11%
Age
11%
Cellular Immunity
10%
Mycobacterium
10%
Gentamicin
10%
Endocarditis
10%
Pseudotumor
10%
Pericardial Fluid
10%
Cefozopran
10%
Attention
10%
Breast Cancer
10%
Pleura Effusion
10%
Electrocardiogram
10%
Echocardiography
10%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
46%
COVID-19
32%
Host
29%
Spike
28%
Monospecific Antibody
27%
Virus
25%
Lipoarabinomannan
21%
Immunocompetent Cell
21%
Cells
21%
SARS-related Coronavirus
21%
Hematopoietic Stem Cell Transplantation
21%
Chemoluminescence
21%
Breakthrough Infection
21%
Dose
21%
ELISA
21%
Bombyx Mori
21%
Rheumatic Disease
21%
Immunocompromised Patient
21%
Sample
18%
Parotitis
18%
Humoral Immunity
17%
Wild Type
17%
Viremia
17%
Mycobacteria
16%
Immunoglobulin G Antibody
15%
Abatacept
14%
Seroconversion
14%
Antibody Response
14%
TNF Inhibitor
14%
Subspecies
14%
Immunity
13%
Mutation
10%
Polymerase Chain Reaction
10%
Adoptive Immunity
10%
Dectin 2
10%
Mortality Rate
10%
Cytopathic Effect
10%
Neutralization
10%
Vaccine Efficacy
10%
Monocyte
9%
Titer
8%
Mouse
8%
Glucocorticoid
7%
Sulfasalazine
7%
Human Leukocyte Antigen
6%
Bone Marrow Derived Dendritic Cell
5%
Immunocompromised Patient
5%
DNA Polymorphism
5%
Species
5%
Meyerozyma guilliermondii
5%